Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups
Crossref DOI link: https://doi.org/10.1007/s00228-014-1687-9
Published Online: 2014-05-27
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qi, Wei-Xiang
Shen, Zan
Tang, Li-Na
Yao, Yang
Text and Data Mining valid from 2014-05-27